Lung cancer is predominantly a disease of older adults. Elderly patients however, are less aggressively treated and under-represented in clinical trials. As a consequence, there are several areas of controversy regarding the staging and treatment of these patients. The goal of this proposal is to use national, population-based data to evaluate several issues related to the staging and treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
The specific aims of the study are to: 1) evaluate the relationship between the number of positive lymph nodes and survival of NSCLC patients with N1 disease after adjustment for other prognostic factors; 2) assess the effectiveness of postoperative radiotherapy (RT) in elderly patients with completely resected stage III NSCLC with N2 disease; 3) determine the role of adjuvant chemotherapy in elderly patients with resected stage III (T4, N0-1) NSCLC; 4) evaluate the effectiveness of RT alone for the primary treatment of elderly stage III patients who are not candidates for combined chemoradiation; and 5) assess the prevalence and identify predictors of severe toxicity requiring hospitalization due to chemotherapy and RT in older patients with advanced stage NSCLC treated in the community. To address these Aims, we will use data from the Surveillance, Epidemiology, and End Results (SEER) registry linked to Medicare claims. The study cohort will be comprised of all patients >65 years of age with histologically confirmed advanced stage NSCLC diagnosed between 1991 and 2002. Sociodemographic data and information on the extent of disease at diagnosis will be obtained from SEER. Data on the initial course of treatment (surgery, chemotherapy, and RT) will be ascertained from both SEER and Medicare claims. Linked census data and information from the Area Resource File will be used to obtain information on socioeconomic status and community level factors such as physician availability. Additional information about the treating physicians' characteristics will be obtained from the American Medical Association's Physician Masterfile. The primary outcome of Aims 1 to 4 will be overall survival and the secondary outcome will be lung cancer-specific survival, as assessed by Medicare and SEER data, respectively. The outcome of Aim 5, treatment toxicity, will be ascertained from Medicare claims.
Each Aim will be evaluated using unadjusted, stratified, and multivariate analyses to control for other important prognostic factors such as socioeconomic characteristics, physician availability, tumor histology, stage, and comorbidities. Additionally, we will use propensity score methods, sensitivity analysis, and instrumental variable techniques to minimize bias inherent to observational studies. The findings from this project will provide information that can directly impact the care of elderly patients with NSCLC and inform the design of future trials of treatment strategies for advanced lung cancer.

Public Health Relevance

Lung cancer is the most common cause of cancer-related mortality among older adults in the United States. Despite the high incidence of lung cancer and high mortality rates, elderly patients are less likely to be vigorously staged, less aggressively treated, and typically under-represented in clinical trials. This study will provide information regarding the efficacy of several therapies and may help resolve several controversies regarding the staging and treatment of elderly patients with advanced stage lung cancer. ? ? ? ? ? ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA131348-01A1
Application #
7523668
Study Section
Health Services Organization and Delivery Study Section (HSOD)
Program Officer
Sansbury, Leah B
Project Start
2008-09-01
Project End
2011-07-31
Budget Start
2008-09-01
Budget End
2009-07-31
Support Year
1
Fiscal Year
2008
Total Cost
$258,064
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Kale, Minal S; Mhango, Grace; Gomez, Jorge E et al. (2017) Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer. Am J Clin Oncol 40:470-476
Sigel, Keith; Lurslurchachai, Linda; Bonomi, Marcelo et al. (2013) Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer. Lung Cancer 82:266-70
Bergamo, Cara; Lin, Jenny J; Smith, Cardinale et al. (2013) Evaluating beliefs associated with late-stage lung cancer presentation in minorities. J Thorac Oncol 8:12-8
Sigel, Keith; Mhango, Grace; Cohen, Jessica et al. (2013) Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease. Ann Surg Oncol 20:1013-9
Smith, Cardinale B; Swanson, Scott J; Mhango, Grace et al. (2013) Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer. J Thorac Oncol 8:73-8
Wisnivesky, Juan P; Bonomi, Marcelo; Lurslurchachai, Linda et al. (2012) Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer. Eur Respir J 40:957-64
Wisnivesky, Juan P; Halm, Ethan A; Bonomi, Marcelo et al. (2012) Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer 118:4478-85
Smith, C B; Nelson, J E; Berman, A R et al. (2012) Lung cancer physicians' referral practices for palliative care consultation. Ann Oncol 23:382-7
Jonnalagadda, Sirisha; Smith, Cardinale; Mhango, Grace et al. (2011) The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer. Chest 140:433-440
Smith, Cardinale B; Bonomi, Marcelo; Packer, Stuart et al. (2011) Disparities in lung cancer stage, treatment and survival among American Indians and Alaskan Natives. Lung Cancer 72:160-4

Showing the most recent 10 out of 13 publications